Gene Therapy in Alzheimer Disease—It May Be Feasible, but Will It Be Beneficial?-Reference-Cited by-同舟云学术

Gene Therapy in Alzheimer Disease—It May Be Feasible, but Will It Be Beneficial?

Published:2018-07-01 Issue:7 Volume:75 Page:791
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Honig Lawrence S.¹²³

Affiliation:

1. Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York

2. The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Herbert and Florence Irving Medical Center, New York, New York

3. GH Sergievsky Center, Columbia University Herbert and Florence Irving Medical Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Reference13 articles.

1. Adeno-associated viral vector (serotype 2)–nerve growth factor for patients with Alzheimer disease: a randomized clinical trial;Rafii;JAMA Neurol

2. Alzheimer’s disease drug development pipeline: 2017.;Cummings;Alzheimers Dement (N Y),2017

3. Accelerating stem cell trials for Alzheimer’s disease.;Hunsberger;Lancet Neurol,2016

4. A phase 1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer’s disease.;Rafii;Alzheimers Dement,2014

5. Treatment of Alzheimer’s disease: current management and experimental therapeutics.;Honig;Curr Transl Geriatr Exp Gerontol Rep,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical and nonsurgical interventions for Alzheimer's disease;COVID-19 in Alzheimer's Disease and Dementia;2023

2. Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies;Brain;2021-12-17

3. Intravenous and Non-invasive Drug Delivery to the Mouse Basal Forebrain Using MRI-guided Focused Ultrasound;BIO-PROTOCOL;2021

4. The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease;Frontiers in Aging Neuroscience;2020-12-07

5. Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer’s disease;Science Advances;2020-01-24